Top Markets
#1 Wiki Cat Wiki Cat +38.93%
#2 Siren Siren +36.06%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.29%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.07%
#5 Velvet Velvet +17.46%
#6 KUB Coin KUB Coin +17.22%
#7 PulseChain PulseChain +17.12%
#8 aPriori aPriori +16.23%
#9 Cysic Cysic +15.45%
#10 OpenEden OpenEden +15.08%
Coin of the day
Wiki Cat Wiki Cat
Instellingen
Taal
DUTCH
Valuta
USD
Thema
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Rang in aandelen #31240
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Aandeelprijs
$0.01084256
Marktkapitalisatie
$13.87M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
1.70%
Land
NZ
Handel BLIS Technologies Limited (BLT)

Categorie

Healthcare
Winst voor BLIS Technologies Limited (BLT)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van BLIS Technologies Limited bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van BLIS Technologies Limited van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE